Detalhe da pesquisa
1.
Phase 1 Study To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Oral Doses of DS-2969b, a Novel GyrB Inhibitor, in Healthy Subjects.
Antimicrob Agents Chemother
; 62(5)2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29439973
2.
Lack of a clinically relevant effect of sugammadex on anti-Xa activity or activated partial thromboplastin time following pretreatment with either unfractionated or low-molecular-weight heparin in healthy subjects.
Int J Clin Pharmacol Ther
; 52(8): 631-41, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24800921
3.
Asenapine pharmacokinetics and tolerability in a pediatric population.
Drug Des Devel Ther
; 12: 2677-2693, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30214156
4.
A Phase I, Single-Ascending-Dose Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DS-2969b, a Novel GyrB Inhibitor.
J Clin Pharmacol
; 58(12): 1557-1565, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29746725
5.
A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of DS-3801b, a Motilin Receptor Agonist, in Healthy Subjects.
J Clin Pharmacol
; 57(9): 1221-1230, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28464321
6.
An LC-MRM method for measuring intestinal triglyceride assembly using an oral stable isotope-labeled fat challenge.
Bioanalysis
; 8(12): 1265-77, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27225968
7.
Quantification, Variability, and Reproducibility of Basal Skeletal Muscle Glucose Uptake in Healthy Humans Using 18F-FDG PET/CT.
J Nucl Med
; 56(10): 1520-6, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26229142
8.
Effect of sugammadex on QT/QTc interval prolongation when combined with QTc-prolonging sevoflurane or propofol anaesthesia.
Clin Drug Investig
; 33(8): 545-51, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23824662